MicroRNAs in metabolic effects with atypical antipsychotics—a scoping review
Background: Metabolic side effects associated with atypical antipsychotics represent a major challenge in the clinical management of schizophrenia, contributing to poor treatment adherence and an increased risk of relapse. MicroRNAs (miRNAs) have emerged as promising diagnostic biomarkers for schizo...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publishing
2026-03-01
|
| Reeks: | Therapeutic Advances in Psychopharmacology |
| Online toegang: | https://doi.org/10.1177/20451253261430603 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|